These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37530674)

  • 21. Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.
    Roe CR
    Semin Neonatol; 2002 Feb; 7(1):37-47. PubMed ID: 12069537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management.
    Shekhawat PS; Matern D; Strauss AW
    Pediatr Res; 2005 May; 57(5 Pt 2):78R-86R. PubMed ID: 15817498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.
    Wajner M; Amaral AU
    Biosci Rep; 2015 Nov; 36(1):e00281. PubMed ID: 26589966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study.
    Vockley J; Burton BK; Berry G; Longo N; Phillips J; Sanchez-Valle A; Chapman KA; Tanpaiboon P; Grunewald S; Murphy E; Lu X; Rahman S; Ray K; Reineking B; Pisani L; Ramirez AN
    J Inherit Metab Dis; 2023 Sep; 46(5):943-955. PubMed ID: 37276053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on mitochondrial fatty acid oxidation disorders.
    Spiekerkoetter U; Mayatepek E
    J Inherit Metab Dis; 2010 Oct; 33(5):467-8. PubMed ID: 20842433
    [No Abstract]   [Full Text] [Related]  

  • 29. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation.
    Rinaldo P; Matern D
    Genet Med; 2000; 2(6):338-44. PubMed ID: 11339654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin.
    Lee SK; Gosselin NH; Jomphe C; McKeever K; Putnam W
    Clin Pharmacol Drug Dev; 2022 Nov; 11(11):1264-1272. PubMed ID: 35908210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing face of disorders of fatty acid oxidation.
    Vockley J
    Mayo Clin Proc; 1994 Mar; 69(3):249-57. PubMed ID: 8133663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inborn errors of mitochondrial fatty acid oxidation.
    Bennett MJ; Rinaldo P; Strauss AW
    Crit Rev Clin Lab Sci; 2000 Feb; 37(1):1-44. PubMed ID: 10737439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological outcomes in fatty acid oxidation disorders: 85 cases detected by newborn screening.
    Waisbren SE; Landau Y; Wilson J; Vockley J
    Dev Disabil Res Rev; 2013; 17(3):260-8. PubMed ID: 23798014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.
    Wanders RJ; Ruiter JP; IJLst L; Waterham HR; Houten SM
    J Inherit Metab Dis; 2010 Oct; 33(5):479-94. PubMed ID: 20490924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enzymes of mitochondrial fatty acid oxidation.
    Bennett MJ
    Clin Chim Acta; 1994 May; 226(2):211-24. PubMed ID: 7923814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study.
    Karunanidhi A; Van't Land C; Rajasundaram D; Grings M; Vockley J; Mohsen AW
    J Inherit Metab Dis; 2022 May; 45(3):541-556. PubMed ID: 35076099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid oxidation disorders: outcome and long-term prognosis.
    Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of mitochondrial long-chain fatty acid oxidation.
    Pollitt RJ
    J Inherit Metab Dis; 1995; 18(4):473-90. PubMed ID: 7494405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
    Wanders RJ; Vreken P; den Boer ME; Wijburg FA; van Gennip AH; IJlst L
    J Inherit Metab Dis; 1999 Jun; 22(4):442-87. PubMed ID: 10407780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.